Plozasiran
VSA001-3001
Phase 3 small_molecule completed
Quick answer
Plozasiran for Familial Chylomicronemia Syndrome is a Phase 3 program (small_molecule) at ARROWHEAD PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ARROWHEAD PHARMACEUTICALS, INC.
- Indication
- Familial Chylomicronemia Syndrome
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed